학술논문
Improved local diagnosis of focal hyperinsulinism in the COVID‐19 era by interstate radiopharmaceutical transport.
Document Type
Article
Author
Source
Subject
*COVID-19 pandemic
*HYPERINSULINISM
*RADIOPHARMACEUTICALS
*VON Hippel-Lindau disease
*ICHTHYOSIS
*
*
*
*
Language
ISSN
1034-4810
Abstract
Improved local diagnosis of focal hyperinsulinism in the COVID-19 era by interstate radiopharmaceutical transport 2013; 98: E1786 - 9. 7 States LJ, Davis JC, Hamel SM, Becker SA, Zhuang H. 18F-6-Fluoro-l-Dopa PET/CT imaging of congenital hyperinsulinism. Interstate transport of SP 18 sp F-DOPA, rather than the infant, resulted in improved patient safety, reduced cost and shorter time to definitive treatment for an infant with focal congenital hyperinsulinism, but is primarily limited by its 8-h expiry window and requires a close collaborative and multidisciplinary approach. [Extracted from the article]